COL-144

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for COL-144, covering 2019-12-02 to 2019-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment [Phase 2]